Openshaw PJM - Search Results

1

SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination.

Liew F, Talwar S, Cross A, Willett BJ, Scott S, Logan N, Siggins MK, Swieboda D, Sidhu JK, Efstathiou C, Moore SC, Davis C, Mohamed N, Nunag J, King C, Thompson AAR, Rowland-Jones SL, Docherty AB, Chalmers JD, Ho LP, Horsley A, Raman B, Poinasamy K, Marks M, Kon OM, Howard L, Wootton DG, Dunachie S, Quint JK, Evans RA, Wain LV, Fontanella S, de Silva TI, Ho A, Harrison E, Baillie JK, Semple MG, Brightling C, Thwaites RS, Turtle L, Openshaw PJM; ISARIC4C Investigators; PHOSP-COVID collaborative group. Liew F, et al. Among authors: openshaw pjm. EBioMedicine. 2023 Jan;87:104402. doi: 10.1016/j.ebiom.2022.104402. Epub 2022 Dec 19. EBioMedicine. 2023. PMID: 36543718 Free PMC article.

2

IL-12 treatment attenuates T helper cell type 2 and B cell responses but does not improve vaccine-enhanced lung illness.

Hussell T, Khan U, Openshaw P. Hussell T, et al. J Immunol. 1997 Jul 1;159(1):328-34. J Immunol. 1997. PMID: 9200470

3

Recent developments in the biology of respiratory syncytial virus: are vaccines and new treatments just round the corner?

Hussell T, Openshaw P. Hussell T, et al. Curr Opin Microbiol. 1999 Aug;2(4):410-4. doi: 10.1016/S1369-5274(99)80072-1. Curr Opin Microbiol. 1999. PMID: 10458984 Review.

4

Mucosal delivery of a respiratory syncytial virus CTL peptide with enterotoxin-based adjuvants elicits protective, immunopathogenic, and immunoregulatory antiviral CD8+ T cell responses.

Simmons CP, Hussell T, Sparer T, Walzl G, Openshaw P, Dougan G. Simmons CP, et al. J Immunol. 2001 Jan 15;166(2):1106-13. doi: 10.4049/jimmunol.166.2.1106. J Immunol. 2001. PMID: 11145691

5

Development of vaccines against common colds.

Olszewska W, Zambon M, Openshaw PJ. Olszewska W, et al. Br Med Bull. 2002;62:99-111. doi: 10.1093/bmb/62.1.99. Br Med Bull. 2002. PMID: 12176853 Review.

6

Prior exposure to live Mycobacterium bovis BCG decreases Cryptococcus neoformans-induced lung eosinophilia in a gamma interferon-dependent manner.

Walzl G, Humphreys IR, Marshall BG, Edwards L, Openshaw PJ, Shaw RJ, Hussell T. Walzl G, et al. Infect Immun. 2003 Jun;71(6):3384-91. doi: 10.1128/IAI.71.6.3384-3391.2003. Infect Immun. 2003. PMID: 12761122 Free PMC article.

7

Role of CCL11 in eosinophilic lung disease during respiratory syncytial virus infection.

Matthews SP, Tregoning JS, Coyle AJ, Hussell T, Openshaw PJ. Matthews SP, et al. J Virol. 2005 Feb;79(4):2050-7. doi: 10.1128/JVI.79.4.2050-2057.2005. J Virol. 2005. PMID: 15681407 Free PMC article.

8

Differential chemokine expression following respiratory virus infection reflects Th1- or Th2-biased immunopathology.

Culley FJ, Pennycook AM, Tregoning JS, Hussell T, Openshaw PJ. Culley FJ, et al. J Virol. 2006 May;80(9):4521-7. doi: 10.1128/JVI.80.9.4521-4527.2006. J Virol. 2006. PMID: 16611912 Free PMC article.

9

Pulmonary V gamma 4+ gamma delta T cells have proinflammatory and antiviral effects in viral lung disease.

Dodd J, Riffault S, Kodituwakku JS, Hayday AC, Openshaw PJ. Dodd J, et al. J Immunol. 2009 Jan 15;182(2):1174-81. doi: 10.4049/jimmunol.182.2.1174. J Immunol. 2009. PMID: 19124761 Free PMC article.

10

Impact of the 2009 influenza pandemic.

Dunning J, Openshaw PJ. Dunning J, et al. Thorax. 2010 Jun;65(6):471-2. doi: 10.1136/thx.2009.133728. Thorax. 2010. PMID: 20522840 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

291 results

Search Page

Filters